Personalized Escitalopram Dosing in Patients With Depression

UnknownOBSERVATIONAL
Enrollment

148

Participants

Timeline

Start Date

July 16, 2020

Primary Completion Date

September 30, 2023

Study Completion Date

November 30, 2023

Conditions
Depressive Disorder, Major
Interventions
DRUG

Escitalopram

"Escitalopram, a selective serotonin reuptake inhibitor (SSRI), is commercially known as ELORYQA®, Elicea®, Escital®,PRAMES® or Lata® in Serbia. The recommended dose for Major depressive disorder is 10mg/day. Based on the individual response, dose can be adjusted and the maximum dose is 20 mg/day; 5 mg/day dose is also available. Escitalopram is also indicated for treatment of Obsessive-compulsive disorder, Generalized anxiety disorder, Social anxiety disorder (Social phobia) and Panic disorder (with or without agoraphobia) by Medicines and Medical Devices Agency of Serbia.~In known CYP2C19 poor metabolizers, initial dose should be 5mg/day during first 2 weeks, and based on the individual response it can be increased up to maximum of 10 mg of escitalopram per day, according to the guidelines of Medicines and Medical Devices Agency of Serbia."

Trial Locations (3)

11000

RECRUITING

Clinical Centre of Serbia, Belgrade

NOT_YET_RECRUITING

Military Medical Academy, Belgrade

Unknown

RECRUITING

Institute of Mental Health, Belgrade

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Clinical Centre of Serbia

OTHER

collaborator

Institute of Mental Health, Serbia

UNKNOWN

collaborator

Military Medical Academy, Belgrade, Serbia

OTHER

lead

University of Belgrade

OTHER